AR245219A1 - Acido nucleico que codifica linfotoxina de secuencias de aminoacidos humana. - Google Patents

Acido nucleico que codifica linfotoxina de secuencias de aminoacidos humana.

Info

Publication number
AR245219A1
AR245219A1 AR86305572A AR30557286A AR245219A1 AR 245219 A1 AR245219 A1 AR 245219A1 AR 86305572 A AR86305572 A AR 86305572A AR 30557286 A AR30557286 A AR 30557286A AR 245219 A1 AR245219 A1 AR 245219A1
Authority
AR
Argentina
Prior art keywords
human amino
amino acid
nucleic acid
acid sequences
codes human
Prior art date
Application number
AR86305572A
Other languages
English (en)
Spanish (es)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of AR245219A1 publication Critical patent/AR245219A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AR86305572A 1984-05-31 1986-10-14 Acido nucleico que codifica linfotoxina de secuencias de aminoacidos humana. AR245219A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US73231285A 1985-05-09 1985-05-09

Publications (1)

Publication Number Publication Date
AR245219A1 true AR245219A1 (es) 1993-12-30

Family

ID=27417179

Family Applications (1)

Application Number Title Priority Date Filing Date
AR86305572A AR245219A1 (es) 1984-05-31 1986-10-14 Acido nucleico que codifica linfotoxina de secuencias de aminoacidos humana.

Country Status (23)

Country Link
EP (2) EP0164965B1 (OSRAM)
JP (3) JP2521703B2 (OSRAM)
AR (1) AR245219A1 (OSRAM)
AT (2) ATE195323T1 (OSRAM)
AU (1) AU599303B2 (OSRAM)
BG (1) BG60256B1 (OSRAM)
CA (1) CA1340641C (OSRAM)
CZ (1) CZ283148B6 (OSRAM)
DE (2) DE3588225T2 (OSRAM)
DK (1) DK171531B1 (OSRAM)
ES (1) ES8802182A1 (OSRAM)
FI (1) FI93025C (OSRAM)
GR (1) GR851317B (OSRAM)
HU (1) HU204085B (OSRAM)
IE (1) IE63487B1 (OSRAM)
IL (1) IL75318A (OSRAM)
NO (1) NO179075C (OSRAM)
NZ (1) NZ212207A (OSRAM)
PL (1) PL155410B1 (OSRAM)
PT (1) PT80573B (OSRAM)
RO (1) RO100383A2 (OSRAM)
SK (1) SK393085A3 (OSRAM)
YU (1) YU47735B (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU564690B2 (en) 1980-04-03 1987-08-20 Biogen Idec Ma Inc. Process for producing human fibroblast interferon-like polypeptides using recombinant dna
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
EP0216786B1 (en) * 1984-12-21 1992-03-18 Biogen, Inc. Purification, production and use of tumor necrosis factors
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
EP0230781B1 (en) * 1985-12-24 1992-07-22 Denki Kagaku Kogyo Kabushiki Kaisha Lymphotoxin gene, method for its production, and lymphotoxin
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
KR100528604B1 (ko) * 1995-01-23 2006-03-16 제노테크 인코포레이티드 골용해와전이를개선하기위한조성물
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
DE69939732D1 (de) 1998-01-15 2008-11-27 Genentech Inc Apo-2 ligand
AU2003302386B2 (en) * 2002-11-26 2010-04-01 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
AU2004252171B2 (en) 2003-06-27 2011-04-21 Biogen Ma Inc. Modified binding molecules comprising connecting peptides
EP1699486A4 (en) * 2003-12-08 2007-07-18 Centocor Inc ANTI-LYMPHOTOXIN HUMAN ALPHA ANTIBODIES, COMPOSITIONS, METHODS AND USES
SG151294A1 (en) 2004-03-23 2009-04-30 Biogen Idec Inc Receptor coupling agents and therapeutic uses thereof
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
US7923011B2 (en) * 2006-10-12 2011-04-12 Genentech, Inc. Antibodies to lymphotoxin-alpha
KR20090071652A (ko) 2006-10-20 2009-07-01 바이오겐 아이덱 엠에이 인코포레이티드 가용성 림프독소-베타-수용체를 이용한 탈수초성 장애의 치료
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
UA122204C2 (uk) * 2014-04-25 2020-10-12 Наурекс, Інк. Стабільні композиції нейроактивних пептидів

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR7908410A (pt) * 1978-12-22 1980-09-09 Biogen Nv Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin

Also Published As

Publication number Publication date
YU47735B (sh) 1996-01-08
EP0164965A3 (en) 1988-04-06
YU91985A (en) 1988-12-31
EP0509553A1 (en) 1992-10-21
PT80573B (pt) 1987-08-19
PT80573A (en) 1985-06-01
ES8802182A1 (es) 1988-04-16
NZ212207A (en) 1991-07-26
DE3588225D1 (de) 2000-09-14
FI852143L (fi) 1985-12-01
SK278333B6 (en) 1996-11-06
BG60256B2 (bg) 1994-03-24
JPS6156197A (ja) 1986-03-20
DK241385D0 (da) 1985-05-30
FI93025C (fi) 1995-02-10
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
DE3587597D1 (de) 1993-11-04
HUT37814A (en) 1986-02-28
CZ393085A3 (en) 1997-07-16
JP2521703B2 (ja) 1996-08-07
IE851321L (en) 1985-11-30
IE63487B1 (en) 1995-05-03
NO179075B (no) 1996-04-22
PL253739A1 (en) 1986-03-11
SK393085A3 (en) 1996-11-06
EP0164965A2 (en) 1985-12-18
DK241385A (da) 1985-12-01
ES543695A0 (es) 1988-04-16
IL75318A0 (en) 1985-09-29
CA1340641C (en) 1999-07-13
EP0164965B1 (en) 1993-09-29
FI852143A0 (fi) 1985-05-29
RO100383B1 (ro) 1991-03-01
DE3588225T2 (de) 2001-04-05
AU599303B2 (en) 1990-07-19
IE930589L (en) 1985-11-30
FI93025B (fi) 1994-10-31
NO852173L (no) 1985-12-02
ATE195323T1 (de) 2000-08-15
CZ283148B6 (cs) 1998-01-14
GR851317B (OSRAM) 1985-11-25
JP2804237B2 (ja) 1998-09-24
HU204085B (en) 1991-11-28
JPH07250692A (ja) 1995-10-03
NO179075C (no) 1996-07-31
IL75318A (en) 1994-08-26
PL155410B1 (en) 1991-11-29
DE3587597T2 (de) 1994-06-01
EP0509553B1 (en) 2000-08-09
JPH07291995A (ja) 1995-11-07
RO100383A2 (ro) 1991-10-17
DK171531B1 (da) 1996-12-23
ATE95243T1 (de) 1993-10-15

Similar Documents

Publication Publication Date Title
AR245219A1 (es) Acido nucleico que codifica linfotoxina de secuencias de aminoacidos humana.
GB8305786D0 (en) Human antithrombim iii dna sequences
EP0259498A4 (en) STRIP CODE LABEL.
GB2217636B (en) Bending tool assembly.
DE3576524D1 (de) Dna-sequenzen.
GB8626914D0 (en) Dna clone
DE3581337D1 (en) Peptide.
EP0256804A3 (en) Code reader
AU2245888A (en) Code reader
GB8610230D0 (en) Dna segment coding
GB8703703D0 (en) Reading bar code
GB2135677B (en) Plasmids comprising sequences which code for trna
GB2211051B (en) Code correlation arrangement
EP0191854A4 (en) ANTI-VIRAL PEPTIDES.
GB8528449D0 (en) Bar code reading system
EP0312346A3 (en) E. coli sequence specific acid protease
GB8627123D0 (en) Dna sequence
GB8424027D0 (en) Bar code readers
GB2212160B (en) Dna sequences encoding the bspmi recognition site.
GB8716938D0 (en) Dna sequence coding
GB8629633D0 (en) Bar code wands
GB8315981D0 (en) Dna sequences
HUT38457A (en) Bar code reader
GB8409753D0 (en) Identifying dna sequences
GB8524726D0 (en) Dna sequences